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Copyright © 2005 by The American Asso-
ciation for Thoracic Surgerydoi:10.1016/j.jtcvs.2004.05.001Objective: We sought to investigate the correlation between type of vascular
reconstruction and long-term graft patency after replacement of brachiocephalic
veins combined with resection of mediastinal malignancies.
Methods: Eighteen patients underwent surgical resection of tumors and the superior
vena cava with concomitant vascular reconstruction using ringed polytetrafluoro-
ethylene grafts. Graft patency was verified by means of venography or contrast-
enhanced computed tomography at time points ranging from 3 to 77 months
(median, 33 months) postoperatively.
Results: Seven patients underwent sole reconstruction of the right brachiocephalic
vein, with occlusion observed in only 1 patient. In 6 patients who underwent
reconstruction of the bilateral brachiocephalic veins with 2 separate grafts, the grafts
remained patent in 2, whereas 4 patients experienced occlusion of one of the two
grafts yet remained asymptomatic. Both patients who underwent reconstruction with
a Y graft experienced left brachiocephalic vein graft occlusion. In the 3 patients who
underwent reconstruction of a left brachiocephalic vein, the graft became occluded,
and superior vena cava syndrome developed in 2 of these patients.
Conclusion: When replacing the superior vena cava, reconstruction of a left bra-
chiocephalic vein alone results in a significant rate of occlusion and development of
superior vena cava syndrome. Thus we advocate sole right brachiocephalic vein
reconstruction or bilateral brachiocephalic vein reconstruction in this setting, and
separate reconstruction of the veins is preferable to use of a Y graft.
Mediastinal tumors tend to invade the large vessels, nerves,lungs, and pericardium, and complete resection often requiresreconstruction of the large vessels. Several investigators havereported favorable results when combining resection of ma-lignant tissue with vascular reconstruction.1,2 For example,Dartevelle and colleagues3 reported good survivals after re-
placement of the superior vena cava (SVC) with a ringed polytetrafluoroethylene
(PTFE) graft combined with resection of mediastinal-pulmonary malignant tumors.
Ringed PTFE grafts have been reported to remain patent for several years4; how-
ever, the correlation between long-term graft patency and type of brachiocephalic
vein (BCV) reconstruction remains unknown. In the present study we characterized
long-term graft patency on the basis of the BCV replacement procedure used.
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From 1986 through 2001, 20 patients with malignant mediastinal
tumors invading the SVC underwent surgical resection at Osaka
University Hospital. Two patients did not undergo a postoperative
evaluation of graft patency and thus were excluded from the final
analysis. Five patients had SVC syndrome before the operation.
Clinicopathologic features of the patient population are summa-
rized in Table 1.
Surgical Procedure
Resection of the mediastinal tumors was performed through a
median sternotomy in all patients. A lobectomy or pulmonary
wedge resection was performed in 13 patients, and a partial peri-
cardiectomy was performed in 7 patients. Additionally, 5 patients
underwent concomitant phrenic nerve resection with diaphragm
plication. Cardiopulmonary bypass was used in 3 patients with
tumor invasion of the right arterial wall to allow for resection of
right atrial tissue.5
Right and Left BCV Reconstruction Procedures
The surgical procedures used are shown in Figure 1. If subclavian
venous pressure was greater than 40 cm H2O after SVC clamping
or if the SVC clamping time without circulatory support was
anticipated to be greater than 45 minutes, reconstruction of the left
TABLE I. Clinicopathologic features of patients and recon
Case no. Age/sex Diagnosis
Reconstruc
vessels
1 65/F Thymoma Rt BCV
2 53/M Thymoma Rt BCV
3 26/M Choriocarcinoma Rt BCV
4 19/M Seminoma Rt BCV
5* 18/M Embryonal carcinoma Rt BCV
6 42/F Thymoma Rt BCV
7 57/F Thymoma Rt BCV
8 65/F Malignant teratoma Lt BCV
9 38/F Malignant lymphoma Lt BCV
10* 53/M Thymic cancer Lt BCV
11* 44/F Thymoma Rt BCV
Lt BCV
12* 50/M Thymoma Rt BCV
Lt BCV
13 77/M Thymoma Rt BCV
Lt BCV
14* 59/M Thymic carcinoma Rt BCV
Lt BCV
15* 67/F Thymic carcinoma Rt BCV
Lt BCV
16* 32/M Embryonal carcinoma Rt BCV
Lt BCV
17 74/M Thymoma Rt BCV
Lt BCV
18 47/F Embryonal carcinoma Rt BCV
Lt BCV
BCV, Brachiocephalic vein; PTFE, polytetrafluoroethylene; Rt, right; Lt, left
*Patients who underwent preoperative chemoradiotherapy.BCV with a PTFE graft or a temporary bypass was performed,
810 The Journal of Thoracic and Cardiovascular Surgery ● Aprifollowed by reconstruction of the right BCV.3,6 Seven patients
underwent reconstruction of the right BCV alone with a PTFE
graft, whereas reconstruction was limited to the left BCV in 3
patients. Reconstruction of both the right and left BCVs was
performed in 8 patients (6 patients received 2 separate grafts, and
2 patients received a Y graft). Anticoagulation was achieved with
oral warfarin (titrated to achieve a prothrombin time/international
normalized ratio of 1.8-2.0) for at least 6 months postoperatively in
all patients.
Results
Operative Mortality and Morbidity
By resection of the large mediastinal veins, tumors were
completely removed from 16 of 18 patients. One of the
remaining 2 patients had pleural dissemination, and the
other had a residual tumor in the aortic wall. No operative
mortality was observed.
Operative complications occurred in 3 patients. One pa-
tient had acute mediastinitis and subsequently underwent an
omentopexy procedure and was discharged 3 months after
the initial operation. Two patients had intrathoracic hemor-
rhage, and a rethoracotomy procedure was required. Late
complications were observed in 3 patients. Two patients
tion of BCVs
PTFE graft
Diameter
(mm)
Graft
patency
(mo)
Occlusive
symptom
Single 10 Patent 36 
Single 16 Patent 20 
Single 10 Patent 3 
Single 12 Patent 60 
Single 12 Occlusive 12 
Single 16 Patent 39 
Single 10 Patent 77 
Single 12 Patent 8 
Single 12 Occlusive 11 
Single 10 Occlusive 8 
Separate 10 Patent 44 
8 Patent 44
Separate 10 Occlusive 21 
10 Patent 33
Separate 10 Patent 26 
10 Occlusive 26
Separate 10 Patent 38 
10 Occlusive 5
Separate 10 Patent 13 
10 Patent 13
Separate 10 Patent 36 
10 Occlusive 8
Y graft 10 Occlusive 12 
10 Occlusive 5
Y graft 10 Patent 11 
8 Occlusive 5struc
ted
.who underwent reconstruction of the left BCV alone had
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tively, and 1 patient who underwent reconstruction with a Y
graft had persistent pleural effusion at 11 months postoper-
atively. These 3 patients were readmitted and treated con-
servatively.
Graft Patency
The types of BCV reconstruction performed and graft pa-
tency results are summarized in Table 1. All patients were
evaluated postoperatively with venography or computed
tomographic examinations (Figure 2) at time points ranging
from 3 to 77 months. The graft remained patent in 6 of 7
patients who underwent sole reconstruction of the right
BCV, whereas 2 of 3 patients who underwent sole recon-
struction of the left BCV had graft occlusion. Of the 6
patients who received 2 separate grafts, 4 patients had
occlusion of one graft, whereas both grafts remained patent
in the other 2 patients. In the 2 patients who received a Y
graft, the left BCV was occluded in both, and 1 of the
patients also had right BCV occlusion.
Discussion
Ringed PTFE grafts have been used for reconstruction of
Figure 1. Types of SVC reconstruction performed in the 
1. a, Right BCV reconstructed with an interposed PTF
between the right BCV and the SVC stump (n  5). b, Gr
appendage (n  2). c, Left BCV reconstructed with in
appendage (n 3). d, Right and left BCVs reconstructed
reconstructed with an interposed PTFE graft with prox
BCV and the SVC stump, and the left BCV reconstructio
appendage. e, Right and left BCVs reconstructed withthe mediastinal veins with much success; however, the
The Journal of Thoracioptimal strategy for SVC reconstruction remains controver-
sial.6-8 The results of the present study suggest a tendency
for a sole left BCV graft to be occlusive postoperatively and
to cause SVC syndrome. In contrast, the right BCV graft
remained patent in 6 of 7 patients who underwent sole
reconstruction of the right BCV. In the present patients there
was no significant difference in the internal diameter of the
grafts between right and left BCV reconstructions (Table 1).
Thus the disparity between patency rates between the right
and left BCVs might have resulted from comparatively
slower flow velocities in the left graft because of its longer
length. Therefore sole reconstruction of the left BCV should
be avoided in patients undergoing resection of the SVC and
left BCV.
Bilateral reconstruction of BCVs has been recommended
to prevent significant subclavian venous hypertension and
secondary lymphatic obstruction, as well as respiratory in-
sufficiency.9,10 However, use of a Y anastomosis necessi-
tates a graft-to-graft suture that promotes thrombotic occlu-
sion.3 Of the 2 patients who received a Y graft in the present
study, 1 had left BCV graft occlusion, and the other had
persistent pleural effusion caused by basal occlusion of the
Y graft. Thus use of a Y graft for SVC reconstruction should
nt series. Case number corresponds with that in Table
aft with proximal and distal end-to-end anastomoses
nastomosed between the right BCV and the right atrial
sed grafts between the left BCV and the right atrial
h 2 separate grafts (n 6), in which the right BCV was
and distal end-to-end anastomoses between the right
s performed between the left BCV and the right atrial
graft (n  2).prese
E gr
aft a
terpo
wit
imal
n wabe avoided. In contrast, although 4 of 6 patients who un-
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one of the grafts, occlusive symptoms were not seen in any
of those patients. An optimal duration of anticoagulant
therapy has not been established4; however, our results
suggest that longer therapy (ie, beyond 6 months) might be
necessary for patients who have undergone reconstruction
of both BCVs to prevent late graft occlusion.
Five of 6 patients who underwent bilateral separate re-
construction in the present study received preoperative che-
moradiotherapy (Table 1). Chemoradiotherapy results in
formation of desmoplastic tissues around the tumor and
makes tumor dissection extremely difficult, with increased
SVC clamping time. Therefore we performed anastomoses
between the left BCV and the right atrial appendage first to
enable safe reconstruction of the right BCV in those pa-
tients. Another advantage of using bilateral grafts is that
even if one of the bilateral grafts is occluded by thrombus
formation or local tumor recurrence, the other will likely
remain patent.7 Thus we advocate the use of bilateral sep-
arate reconstruction for SVC replacement.
In the present series graft occlusion was detected from 5
to 26 months postoperatively, and therefore long-term fol-
low-up is necessary to accurately evaluate the graft patency.
This can be easily accomplished by contrast-enhanced com-
puted tomography, which is also performed to determine
Figure 2. Representative computed tomographic ima
computed tomographic images showing satisfactory p
and d, Contrast computed tomographic images showing
of a left BCV graft.disease recurrence.
812 The Journal of Thoracic and Cardiovascular Surgery ● ApriIn conclusion, sole reconstruction of a left BCV should
be avoided for SVC replacement. We advocate the use of
bilateral separate reconstruction and avoidance of a Y graft.
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